Chemed Corporation (CHE)
NYSE: CHE · IEX Real-Time Price · USD
560.42
-12.92 (-2.25%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Chemed Revenue
In the year 2023, Chemed had annual revenue of $2.26B with 6.06% growth. Revenue in the quarter ending December 31, 2023 was $585.91M with 7.18% year-over-year growth.
Revenue (ttm)
$2.26B
Revenue Growth
+6.06%
P/S Ratio
3.75
Revenue / Employee
$150,091
Employees
15,087
Market Cap
8.48B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.26B | 129.45M | 6.06% |
Dec 31, 2022 | 2.13B | -4.30M | -0.20% |
Dec 31, 2021 | 2.14B | 59.68M | 2.87% |
Dec 31, 2020 | 2.08B | 141.03M | 7.27% |
Dec 31, 2019 | 1.94B | 155.91M | 8.75% |
Dec 31, 2018 | 1.78B | 115.92M | 6.96% |
Dec 31, 2017 | 1.67B | 89.84M | 5.70% |
Dec 31, 2016 | 1.58B | 33.49M | 2.17% |
Dec 31, 2015 | 1.54B | 87.11M | 5.98% |
Dec 31, 2014 | 1.46B | 42.95M | 3.04% |
Dec 31, 2013 | 1.41B | -16.71M | -1.17% |
Dec 31, 2012 | 1.43B | 74.07M | 5.46% |
Dec 31, 2011 | 1.36B | 75.43M | 5.89% |
Dec 31, 2010 | 1.28B | 90.31M | 7.59% |
Dec 31, 2009 | 1.19B | 41.30M | 3.59% |
Dec 31, 2008 | 1.15B | 48.88M | 4.44% |
Dec 31, 2007 | 1.10B | 81.47M | 8.00% |
Dec 31, 2006 | 1.02B | 102.62M | 11.20% |
Dec 31, 2005 | 915.97M | 181.09M | 24.64% |
Dec 31, 2004 | 734.88M | 474.10M | 181.80% |
Dec 31, 2003 | 260.78M | 7.09M | 2.79% |
Dec 31, 2002 | 253.69M | -84.22M | -24.92% |
Dec 31, 2001 | 337.91M | -17.40M | -4.90% |
Dec 31, 2000 | 355.31M | -90.29M | -20.26% |
Dec 31, 1999 | 445.60M | 64.32M | 16.87% |
Dec 31, 1998 | 381.28M | 39.55M | 11.57% |
Dec 31, 1997 | 341.73M | 40.52M | 13.45% |
Dec 31, 1996 | 301.21M | 30.76M | 11.38% |
Dec 31, 1995 | 270.45M | -374.58M | -58.07% |
Dec 31, 1994 | 645.03M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Henry Schein | 12.34B |
Encompass Health | 4.80B |
AptarGroup | 3.54B |
Qiagen | 1.97B |
Stevanato Group | 1.21B |
Penumbra | 1.06B |
Repligen | 638.76M |
Legend Biotech | 285.14M |
CHE News
- 3 days ago - Chemed Reports First-Quarter 2024 Results - Business Wire
- 10 days ago - VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama - Business Wire
- 26 days ago - Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25 - Business Wire
- 6 weeks ago - VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama - Business Wire
- 7 weeks ago - Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference - Business Wire
- 2 months ago - Chemed Reports Fourth-Quarter 2023 Results - Business Wire
- 2 months ago - Chemed Corporation Declares Quarterly Dividend of 40 Cents - Business Wire
- 2 months ago - Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28 - Business Wire